Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Daniel, Kosztyla"'
Autor:
Budczies Jan, Daniel Kosztyla, Christian von Törne, Albrecht Stenzinger, Silvia Darb-Esfahani, Manfred Dietel, Carsten Denkert
Publikováno v:
Journal of Statistical Software, Vol 59, Iss 1, Pp 1-19 (2014)
Progress in molecular high-throughput techniques has led to the opportunity of a comprehensive monitoring of biomolecules in medical samples. In the era of personalized medicine, these data form the basis for the development of diagnostic, prognostic
Externí odkaz:
https://doaj.org/article/518d992b778141d08f4bf4f5df655496
Autor:
Monika Sparber‐Sauer, Andrea Ferrari, Daniel Kosztyla, Ruth Ladenstein, Giovanni Cecchetto, Bernarda Kazanowska, Giovanni Scarzello, Gustaf Ljungman, Giuseppe Maria Milano, Felix Niggli, Rita Alaggio, Christian Vokuhl, Michela Casanova, Thomas Klingebiel, Angelica Zin, Ewa Koscielniak, Gianni Bisogno
Publikováno v:
Pediatric Blood & Cancer. 69
Background: CWS/RMS-96 was an international multicenter trial with randomization between two therapy arms of the standard four-drug therapy (vincristine, ifosfamide, adriamycin, dactinomycin [VAIA]) versus an intensified six-drug regimen (carboplatin
Autor:
Gustaf Ljungman, Beate Timmermann, Rudolf Hagen, Stefanie Kube, Daniel Kosztyla, Rupert Handgretinger, Simone Feuchtgruber, Thomas Klingebiel, Tobias M. Dantonello, Felix Niggli, Ruth Ladenstein, Monika Stark, Bernarda Kazanowska, Ewa Koscielniak, Jörg Fuchs, Barbara Selle, Stefan S. Bielack, Christin Linderkamp
Publikováno v:
Pediatric Blood & Cancer. 62:16-23
Background Response (tumour volume reduction) to induction chemotherapy has been used to stratify secondary local and systemic treatment of Intergroup Rhabdomyosarcoma Study Group III (IRSG-III) embryonal rhabdomyosarcoma (RME) in consecutive CWS-tri
Autor:
Ivo Leuschner, Thomas Klingebiel, Daniel Kosztyla, Jörg Fuchs, Tobias M. Dantonello, Guido Seitz, Ewa Koscielniak
Publikováno v:
Journal of Urology. 192:902-907
Children with paratesticular rhabdomyosarcoma have a favorable prognosis. Surgical treatment problems include inadequate primary transscrotal approaches, incomplete tumor resections and the need for secondary hemiscrotectomy. We evaluated the need fo
Autor:
Tobias M. Dantonello, Ivo Leuschner, Daniel Kosztyla, Thomas Klingebiel, Guido Seitz, Joerg Fuchs, Gunnar Blumenstock, Ewa Koscielniak, Andreas Schuck, Felix Niggli
Publikováno v:
Annals of Surgery. 259:1166-1172
OBJECTIVES: To analyze the clinical course, treatment, complications, outcome, and quality of life (QOL) in patients with perineal/perianal rhabdomyosarcoma (PRMS) treated within the CWS-86, -91, -96, and -2002P trials. BACKGROUND:: Although multiple
Autor:
Tobias M, Dantonello, Monika, Stark, Beate, Timmermann, Jörg, Fuchs, Barbara, Selle, Christin, Linderkamp, Rupert, Handgretinger, Rudolf, Hagen, Simone, Feuchtgruber, Stefanie, Kube, Daniel, Kosztyla, Bernarda, Kazanowska, Ruth, Ladenstein, Felix, Niggli, Gustaf, Ljungman, Stefan S, Bielack, Thomas, Klingebiel, Ewa, Koscielniak
Publikováno v:
Pediatric bloodcancer. 62(1)
Response (tumour volume reduction) to induction chemotherapy has been used to stratify secondary local and systemic treatment of Intergroup Rhabdomyosarcoma Study Group III (IRSG-III) embryonal rhabdomyosarcoma (RME) in consecutive CWS-trials. To eva
Autor:
Erik Sköldenberg, Iris Veit-Friedrich, Thomas Klingebiel, Helmut Lochbühler, Tobias M. Dantonello, Erika Hallmen, Markus Franke, Stefan S. Bielack, Jan Godzinski, Ewa Koscielniak, Andreas Schuck, Gustaf Ljungman, Stefanie Kube, Daniel Kosztyla, R. Wessalowski, Simone Feuchtgruber
Publikováno v:
Annals of surgical oncology. 21(11)
Embryonal rhabdomyosarcoma is the most common pediatric soft tissue sarcoma. The best local treatment in large, nonmetastatic primary unresected nongenitourinary embryonal rhabdomyosarcoma of the abdomen (LARME) is however unclear.We analyzed patient
Autor:
Gustaf Ljungman, Tobias M. Dantonello, Thekla von Kalle, Ewa Koscielniak, Marc W. Muenter, Andreas Schuck, Daniel Kosztyla, Heike Scheithauer, Stefan S. Bielack, Ruth Ladenstein, Thomas Klingebiel, Felix Niggli, Rupert Handgretinger, Bernarda Kazanowska, Guido Seitz, Ivo Leuschner
Publikováno v:
Journal of Clinical Oncology. 32:10005-10005
10005 Background: RTX is an essential therapy modality in the treatment of RMS. However, RTX is associated with severe late effects, therefore the indication and the optimal dose are still a matter...
Autor:
Rupert Handgretinger, Ivo Leuschner, Ruediger Fengler, Stefanie Kube, Daniel Kosztyla, Gustaf Ljungman, Iris Veit-Friedrich, Felix Niggli, Thekla von Kalle, Tobias M. Dantonello, Stefan S. Bielack, Peter Kaatsch, Ewa Koscielniak, Peter Winkler, Thomas Klingebiel
Publikováno v:
Journal of Clinical Oncology. 30:9573-9573
9573 Background: Most patients with pediatric soft tissue sarcoma (PSTS) achieve a 1st remission with primary therapy, but recurrences are frequent and drive mortality. Relapse detection (RD) is the foundation of post-treatment surveillance. The rati